Compared with healthy controls, Holmer et al. [17] found an increased fracture risk in women with childhood onset GHD (CO-GHD) using GH replacement therapy, but a decreased fracture risk in men with adult onset GHD (AO-GHD) using GH replacement therapy. The gene discussed is GH1; the disease is Childhood onset.